Physician profile
Anthony L Marcotte
NPI 1144278300
$1,605.75
in general payments reported to CMS, 2019-2025
24 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $222 · 2021: $113 · 2022: $101 · 2023: $66.45 · 2024: $464 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $263.74 | 2019-2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Gamma |
| Acumed LLC | $231.74 | 2022-2025 | Acumed, Osteomed, Innate Implant |
| Orthofix Medical, INC. | $208.62 | 2021-2024 | Physio-Stim |
| Medtronic USA, INC. | $136.81 | 2020 | |
| Amgen INC. | $101.47 | 2022-2025 | Prolia, Evenity, Krystexxa |
| Globus Medical, INC. | $100.61 | 2019 | |
| Arthrosurface Incorporated | $68.43 | 2025 | Wristmotion Wrist Hemiarthroplasty System |
| Endo USA, INC. | $67.83 | 2024-2025 | Xiaflex |
| Cerapedics INC. | $58.92 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Integra Lifesciences Corporation | $57.29 | 2019-2023 | Tenoglide |
| Bioventus LLC | $53.41 | 2020-2024 | Exogen Ultrasound Bone Healing System |
| Biocircuit Technologies INC | $27.05 | 2025 | Nerve Tape |
| Horizon Therapeutics Plc | $26.86 | 2019-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $23.09 | 2024 | Quickanchor Orthocord, Dynacord, Dynatape |
| Kerecis Limited | $22.60 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.07 | 2025 | Plasmablade(Tm) |
| Pacira Pharmaceuticals Incorporated | $20.52 | 2024 | Exparel |
| Welch Allyn | $18.37 | 2021 | |
| Checkpoint Surgical, INC | $17.80 | 2024 | Checkpoint Stimulators |
| Forte Bio-Pharma LLC | $17.62 | 2019 | |
| Smith+Nephew, INC. | $16.39 | 2022 | |
| Zimmer Biomet Holdings, INC. | $15.24 | 2021 | |
| Abbott Laboratories | $14.77 | 2024 | Proclaim |
| Coastal Medical Technologies LLC | $14.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Marcotte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.